Subclinical Hypothyroidism and Cognitive Impairment

Area of Science:

• Endocrinology
• Neurology
• Geriatrics

Background:

• Thyroid dysfunction is a potential cause of reversible cognitive impairment.
• The link between subclinical hypothyroidism and cognitive impairment remains controversial.
• Subclinical hypothyroidism (sHypo) is defined as normal thyroid hormone levels with elevated thyroid-stimulating hormone.

Purpose of the Study:

• To compare cognitive profiles in euthyroid and subclinical hypothyroid patients.
• To assess the association between subclinical hypothyroidism and cognitive decline progression.
• To investigate disease progression from mild cognitive impairment (MCI) to dementia over 3 years.

Main Methods:

• 2,181 euthyroid and 284 sHypo patients over 60 years underwent cognitive assessment.
• Propensity score matching created comparable groups (1,118 euthyroid, 283 sHypo).
• Cognitive functions (attention, language, memory, executive function) were compared; Cox regression analyzed MCI to dementia progression.

Main Results:

• No significant differences in cognitive profiles were observed between euthyroid and sHypo groups.
• Subclinical hypothyroidism was not associated with an increased risk of progression from MCI to dementia.
• No association was found between sHypo or sHypo10 (TSH > 10 mIU/L) and disease progression.

Conclusions:

• Subclinical hypothyroidism does not appear to impact cognitive function or progression to dementia in older adults.
• These findings suggest that hormone therapy for subclinical hypothyroidism may not be beneficial for cognitive impairment.
• Further research is warranted to clarify the role of hormone therapy in managing cognitive changes associated with subclinical hypothyroidism.